Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2021 - 2026)

Ironwood Pharmaceuticals (IRWD) reported Return on Invested Capital of 0.02% for Q1 2026, down 651.34% sequentially from 0.0% in Q4 2025.

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2021 - 2026) Analysis & Trends

Ironwood Pharmaceuticals (IRWD) has 6 years of Return on Invested Capital data on file, last reported at 0.02% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Haleon 88.58 Bn 86.72 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn 0.01%
3 Zoetis 32.33 Bn 30.39 Bn 1.62 Bn 0.01%
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn 0.00%
5 United Therapeutics 23.14 Bn 20.99 Bn 648.10 Mn -
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn 0.00%
8 Neurocrine Biosciences 17.93 Bn 16.62 Bn 800.70 Mn -
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn 0.03%
10 Ironwood Pharmaceuticals 633.37 Mn 412.90 Mn - -0.02%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.02%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.02%
Sep 30, 2023 -0.03%
Dec 31, 2022 0.01%
Sep 30, 2022 0.01%
Jun 30, 2022 0.00%
Mar 31, 2022 0.01%
Dec 31, 2021 0.02%
Sep 30, 2021 0.04%